TAS2R20 IDG GPCR ARCHS4 coexpression (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with TAS2R20 IDG GPCR ARCHS4 coexpression.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with TAS2R20 IDG GPCR ARCHS4 coexpression.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with TAS2R20 IDG GPCR ARCHS4 coexpression.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with TAS2R20 IDG GPCR ARCHS4 coexpression.

Results found

Linked to

 

Label

Description

 

Gene

SMG1 pseudogene 3

Gene

SMG1 pseudogene 1

Gene

zinc finger protein 286B (pseudogene)

Gene

Down syndrome critical region 4

Gene

ankyrin repeat domain 18E, pseudogene

Gene

ZKSCAN8 pseudogene 1

Gene

SUGT1 pseudogene 1

Gene

vomeronasal 1 receptor 110 pseudogene

Gene

solute carrier family 25 member 5 pseudogene 5

Gene

cytochrome P450 family 2 subfamily AB member 1, pseudogene

  • Gene

    SMG1 pseudogene 3


  • Gene

    SMG1 pseudogene 1


  • Gene

    zinc finger protein 286B (pseudogene)


  • Gene

    Down syndrome critical region 4


  • Gene

    ankyrin repeat domain 18E, pseudogene


  • Gene

    ZKSCAN8 pseudogene 1


  • Gene

    SUGT1 pseudogene 1


  • Gene

    vomeronasal 1 receptor 110 pseudogene


  • Gene

    solute carrier family 25 member 5 pseudogene 5


  • Gene

    cytochrome P450 family 2 subfamily AB member 1, pseudogene

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.